SGRY Forecast



Bearish<—>Bullish



80% Confidence




Bullish Case: Known: SGRY trades ~13.49 with a backwardated IV term structure (near-term IV is higher). Recent Q1 2026 results showed revenue growth ~4.5% and EBITDA resilience; Jefferies raised their target to $17, implying upside is recognized by some sell-side. Inferred: activist governance pressure and cost discipline could unlock operating leverage and margin expansion in H2 2026. Uncertain: sustained volume recovery and payer mix normalization remain pivotal. If these offsets occur, a re-rating toward the high-teens is plausible, supported by near-term call activity and favorable option skew.




Bearish Case: Known: stock is flat year-to-date and has high near-term option IV despite modest top-line growth. Inferred: leverage and ongoing EBITDA margin pressures (4.3x) risk delaying meaningful re-rating; same-facility growth is running ~0.6%, signaling only modest demand rebound. Uncertain: macro health-care spending and payer policy shifts could erode margins. If volumes fail to recover and costs remain elevated, downside to the low-teens is a realistic scenario.




Potential Outcomes:
  1. Upside breakout (13.5%–19%): 28% probability. Rationale: activist governance moves forward; payer mix stabilizes; EBITDA margins expand; price targets around $17+ get re-rated if Q3/Q4 results surprise positively.
  2. Range-bound drift (11–14): 32% probability. Rationale: backwardated IV persists; volumes modestly improve but fail to trigger a re-rate; consolidation in earnings and guidance keeps price in a band.
  3. Moderate downside (8–11): 15% probability. Rationale: continued cost pressure and slow volume recovery; any negative guidance or one-time headwinds compress margins and drift price lower.
  4. Major catalyst rally (>18): 10% probability. Rationale: a supralinear margin expansion from cost cuts/ops improvements combined with activist milestones; a favorable re-rating of multiple-year cash-flow power.
  5. Liquidity/macro shock (5–7): 15% probability. Rationale: broader market stress or policy shifts hitting hospital operators could force a flight-to-safety and compress equities in this name.



May 21, 2026


Surgery Forecast

SGRY        Surgery

4 Day Price Forecast + Historical Performance.  (?)

9 Day Price Forecast + Historical Performance.  (?)

20 Day Price Forecast + Historical Performance.  (?)

36 Day Price Forecast + Historical Performance.  (?)

49 Day Price Forecast + Historical Performance.  (?)

















Become a more profitable trader with AI optimized trading strategies